Analysis of the T cells in the tumor-bearing mice showed that the percentage of CD44+CD62L− effector memory CD8+ T cells was greater for mice vaccinated with HM SNAs, when compared with admix treated group (p < 0.01, Figure 5F). Here, CD44 is linked to neoplasm.